These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15704616)

  • 1. Simulation study of the relationship between variation in bioavailability and clinical equivalence using a direct link model.
    Matsumoto Y; Shimizu M; Ogata H
    Int J Clin Pharmacol Ther; 2005 Jan; 43(1):57-62. PubMed ID: 15704616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
    Daley-Yates PT; Gregory AJ; Brooks CD
    Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new PK equivalence test for a bridging study.
    Novick SJ; Zhang X; Yang H
    J Biopharm Stat; 2016; 26(5):992-1002. PubMed ID: 26882145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.
    Schall R; Luus HG; Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):323-8. PubMed ID: 7952792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.
    Sathe P; Venitz J; Lesko L
    Pharm Res; 1999 Jun; 16(6):939-43. PubMed ID: 10397617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A limited sampling approach in bioequivalence studies: application to long half-life drugs and replicate design studies.
    Mahmood I; Mahayni H
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):275-81. PubMed ID: 10395118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of absorption rates in bioequivalence studies of immediate release drug formulations.
    Schall R; Luus HG
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):153-9. PubMed ID: 1592542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.
    Endrenyi L; Fritsch S; Yan W
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):394-9. PubMed ID: 1748540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers.
    Tian Y; Zhang JJ; Feng SD; Zhang ZJ; Chen Y
    Arzneimittelforschung; 2008; 58(10):497-500. PubMed ID: 19025058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of average and population bioequivalence approach.
    Nakai K; Fujita M; Tomita M
    Int J Clin Pharmacol Ther; 2002 Sep; 40(9):431-8. PubMed ID: 12358161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence.
    Marston SA; Polli JE
    Pharm Res; 1997 Oct; 14(10):1363-9. PubMed ID: 9358548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
    Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of 80%-125% for AUC and 70%-143% for Cmax. What is the impact on bioequivalence studies?
    Hauck WW; Parekh A; Lesko LJ; Chen ML; Williams RL
    Int J Clin Pharmacol Ther; 2001 Aug; 39(8):350-5. PubMed ID: 11515710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.
    Endrenyi L; Tothfalusi L
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies.
    Schall R; Hundt HK; Luus HG
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):633-7. PubMed ID: 7881699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence evaluation of menthol after oral administration of peppermint oil soft capsules in dogs.
    Wu JF; Xiang BR; Li KX
    Arzneimittelforschung; 2010; 60(8):479-82. PubMed ID: 20863003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.